X
Monday, May 19, 2025
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development

    Continuous Manufacturing is Improving Biopharma Production

    AI in Drug Commercialization Market to Grow CAGR 24% by 2032

    Continuous Bioprocessing Market to Surge by 2028

    Advancing Asia-Pacific Healthcare & Biopharma Innovation

    Generative AI in Pharma: Opportunities & Challenges

    Global Biopharma Market to Hit $566B by 2032

    AI Boosts Small Molecule Therapies for I&I Diseases

    Celonic Group Signs Long-Term Multi-Year Manufacturing Service Agreement with LINDIS Biotech for the Commercial Supply of Catumaxomab

    Novartis bolsters late-stage cardiovascular pipeline with agreement to acquire Anthos Therapeutics for USD 925 million upfront

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Research & Development

FierceBiotech’sDrug Development Forum Attracts Executive-Level Biopharma Professionals for Second Annual Conference in Boston This September

Yuvraj_pawp by Yuvraj_pawp
21st June 2017
in Research & Development

Attendees of FierceBiotech’s 2ndAnnual Drug Development Forum will obtain essential funding strategies and more productive R&D through executive-level networking opportunities.

Convening at the Renaissance Boston Waterfront Hotel September 25–27, 2017, the conference draws together the industry’s top decision makers to help guide to success throughout the entire lifecycle — both for products and businesses.


“Our primary objective behind this conference is to build a program for the industry, by the industry and we’ve been working very closely with our advisory board, our readers, and key industry leaders to develop a program that digs into the real issues facing our industry,” said Rebecca Willumson, VP and Publisher of FierceBiotech.


Some sample sessions include:

Meet Increasing Demands for Real-World Evidence
Donald Bergstrom, CMO, MERSANA THERAPEUTICS

Shorten the Path From Preclinical to Clinical Phases
John Hohneker, Executive Vice President, Head of R&D, FORMA THERAPEUTICSSara Nochur, Senior Vice President, Regulatory Affairs, ALNYLAMPHARMACEUTICALS
Richard Gregory, CSO, IMMUNOGEN
Timothy Lowinger, CSO, MERSANA THERAPEUTICS


Enable Flexibility, Creativity and Independence in Partnerships Between Large and Small Biotech Companies

Michael Bailey, CEO, AVEO ONCOLOGY
Chandra Ramanathan, Vice President and Head, East Coast Innovation Center, BAYER
Cynthia Schwalm, President, North American Commercial Operations, IPSEN
Rich Murray, CEO, JOUNCE THERAPEUTICS


Add Orphan Indications to Accelerate Development

Krishna Menon, CSO, CELLCEUTIX
John Lee, CMO, PHASEBIO PHARMACEUTICALS


How to Succeed in Novel Deal Structures (Even If They’re Trying)

Richard Brudnick, Executive Vice President, Business Development, BIOVERATIVMichael Aberman, Vice President, Strategy and Investor Relations, REGENERONLindsay Rosenwald, CEO, FORTRESS BIOTECH

ABOUT FIERCEBIOTECH
FierceBiotech is the biotech industry’s daily monitor, an email newsletter and web resource providing the latest biotech news, articles, and resources related to clinical trials, drug discovery, FDA approval, FDA regulation, patent news, pharma news, biotech company news and more. An internationally recognized daily report reaching a network of over 275,000 biotech and pharma industry professionals, FierceBiotech provides subscribers with an authoritative analysis of the day’s top stories.
www.fiercebiotech.com


ABOUT EXL EVENTS

ExL Events, a division of Questex, LLC, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical and allied healthcare communities in the United States, Europe, Latin America and additional markets.
www.exlevents.com

 

CONTACT
For information on exhibiting and sponsorship opportunities, please contact Andrew Sinetar at 212-400-6237 or asinetar@exlevents.com

 

RELATED LINK
www.FierceDrugDevForum.com

Previous Post

KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Capabilities

Next Post

LEO Pharma appoints Chris Posner to lead US business

Related Posts

Drug Development

Continuous Bioprocessing Market to Surge by 2028

7th March 2025
Insights

Advancing Asia-Pacific Healthcare & Biopharma Innovation

7th March 2025
Insights

Generative AI in Pharma: Opportunities & Challenges

7th March 2025
Drug Development

Global Biopharma Market to Hit $566B by 2032

7th March 2025
Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials
News

Detect-ION and Moffitt Cancer Center Collaborate to Revolutionize Lung Cancer Early Detection

19th August 2024
News

Scaling Cell And Gene Therapies: Challenges And Solutions

11th August 2024
Next Post

LEO Pharma appoints Chris Posner to lead US business

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Notifications